Injectable Porous Bioresorbable Composite Containing Fluvastatin for Bone Augmentation

Tianren Zhou, Yasuko Moriyama, Yasunori Ayukawa, Yunia Dwi Rakhmatia, Xudiyang Zhou, Jiangqi Hu, Kiyoshi Koyano

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to evaluate the effects of an injectable composite made up of calcium sulfate (CAS), fluvastatin (FS), and atelocollagen on bone augmentation in rats. Porous structures and compressive strength of composites were evaluated. The cumulative release kinetics of FS were determined in vitro by a spectrophotometer. To observe bone regeneration in vivo, five different materials (normal saline; atelocollagen gel only; composite of CAS and atelocollagen; composite containing 0.5% FS; and composite containing 1.0% FS) were injected in extraction sockets and in the crania of rats. Microcomputed tomography and histological evaluation were performed after 2, 4, and 8 weeks of healing time. The composites had high porosity (greater than 55%). FS kept a slow and stable release for >30 days. In vivo results demonstrated that more new bone was formed in the FS groups compared with the other groups, and both bone mass and bone density had prominent increase in maxillae and crania. Resorption of the composite was also observed for cranial tissues. In conclusion, this composite can be applied percutaneously, without any incision. It has excellent properties with replaceability into bone and anabolic effects for bone formation, as well as a drug delivery system for bone formation.

Original languageEnglish
Pages (from-to)5422-5429
Number of pages8
JournalACS Biomaterials Science and Engineering
Volume5
Issue number10
DOIs
Publication statusPublished - Oct 14 2019

Fingerprint

fluvastatin
Bone
Composite materials
Calcium Sulfate
Rats
Calcium
Anabolic Agents
Spectrophotometers

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

Injectable Porous Bioresorbable Composite Containing Fluvastatin for Bone Augmentation. / Zhou, Tianren; Moriyama, Yasuko; Ayukawa, Yasunori; Rakhmatia, Yunia Dwi; Zhou, Xudiyang; Hu, Jiangqi; Koyano, Kiyoshi.

In: ACS Biomaterials Science and Engineering, Vol. 5, No. 10, 14.10.2019, p. 5422-5429.

Research output: Contribution to journalArticle

@article{d932120185344bdd9322f80774801773,
title = "Injectable Porous Bioresorbable Composite Containing Fluvastatin for Bone Augmentation",
abstract = "The purpose of this study was to evaluate the effects of an injectable composite made up of calcium sulfate (CAS), fluvastatin (FS), and atelocollagen on bone augmentation in rats. Porous structures and compressive strength of composites were evaluated. The cumulative release kinetics of FS were determined in vitro by a spectrophotometer. To observe bone regeneration in vivo, five different materials (normal saline; atelocollagen gel only; composite of CAS and atelocollagen; composite containing 0.5{\%} FS; and composite containing 1.0{\%} FS) were injected in extraction sockets and in the crania of rats. Microcomputed tomography and histological evaluation were performed after 2, 4, and 8 weeks of healing time. The composites had high porosity (greater than 55{\%}). FS kept a slow and stable release for >30 days. In vivo results demonstrated that more new bone was formed in the FS groups compared with the other groups, and both bone mass and bone density had prominent increase in maxillae and crania. Resorption of the composite was also observed for cranial tissues. In conclusion, this composite can be applied percutaneously, without any incision. It has excellent properties with replaceability into bone and anabolic effects for bone formation, as well as a drug delivery system for bone formation.",
author = "Tianren Zhou and Yasuko Moriyama and Yasunori Ayukawa and Rakhmatia, {Yunia Dwi} and Xudiyang Zhou and Jiangqi Hu and Kiyoshi Koyano",
year = "2019",
month = "10",
day = "14",
doi = "10.1021/acsbiomaterials.9b01045",
language = "English",
volume = "5",
pages = "5422--5429",
journal = "ACS Biomaterials Science and Engineering",
issn = "2373-9878",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Injectable Porous Bioresorbable Composite Containing Fluvastatin for Bone Augmentation

AU - Zhou, Tianren

AU - Moriyama, Yasuko

AU - Ayukawa, Yasunori

AU - Rakhmatia, Yunia Dwi

AU - Zhou, Xudiyang

AU - Hu, Jiangqi

AU - Koyano, Kiyoshi

PY - 2019/10/14

Y1 - 2019/10/14

N2 - The purpose of this study was to evaluate the effects of an injectable composite made up of calcium sulfate (CAS), fluvastatin (FS), and atelocollagen on bone augmentation in rats. Porous structures and compressive strength of composites were evaluated. The cumulative release kinetics of FS were determined in vitro by a spectrophotometer. To observe bone regeneration in vivo, five different materials (normal saline; atelocollagen gel only; composite of CAS and atelocollagen; composite containing 0.5% FS; and composite containing 1.0% FS) were injected in extraction sockets and in the crania of rats. Microcomputed tomography and histological evaluation were performed after 2, 4, and 8 weeks of healing time. The composites had high porosity (greater than 55%). FS kept a slow and stable release for >30 days. In vivo results demonstrated that more new bone was formed in the FS groups compared with the other groups, and both bone mass and bone density had prominent increase in maxillae and crania. Resorption of the composite was also observed for cranial tissues. In conclusion, this composite can be applied percutaneously, without any incision. It has excellent properties with replaceability into bone and anabolic effects for bone formation, as well as a drug delivery system for bone formation.

AB - The purpose of this study was to evaluate the effects of an injectable composite made up of calcium sulfate (CAS), fluvastatin (FS), and atelocollagen on bone augmentation in rats. Porous structures and compressive strength of composites were evaluated. The cumulative release kinetics of FS were determined in vitro by a spectrophotometer. To observe bone regeneration in vivo, five different materials (normal saline; atelocollagen gel only; composite of CAS and atelocollagen; composite containing 0.5% FS; and composite containing 1.0% FS) were injected in extraction sockets and in the crania of rats. Microcomputed tomography and histological evaluation were performed after 2, 4, and 8 weeks of healing time. The composites had high porosity (greater than 55%). FS kept a slow and stable release for >30 days. In vivo results demonstrated that more new bone was formed in the FS groups compared with the other groups, and both bone mass and bone density had prominent increase in maxillae and crania. Resorption of the composite was also observed for cranial tissues. In conclusion, this composite can be applied percutaneously, without any incision. It has excellent properties with replaceability into bone and anabolic effects for bone formation, as well as a drug delivery system for bone formation.

UR - http://www.scopus.com/inward/record.url?scp=85073009159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073009159&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.9b01045

DO - 10.1021/acsbiomaterials.9b01045

M3 - Article

AN - SCOPUS:85073009159

VL - 5

SP - 5422

EP - 5429

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

SN - 2373-9878

IS - 10

ER -